FDA Inspection 938183 — Novartis Pharma Schweizerhalle Ag
The FDA completed an inspection of Novartis Pharma Schweizerhalle Ag on July 14, 2015 in Pratteln. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 14, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Pratteln (Switzerland)